AJANTPHARM

Ajanta Pharma Share Price

 

 

Invest in Ajanta Pharma with 3.43X leverage

Invest with MTF

Performance

  • Low
  • ₹2,826
  • High
  • ₹2,878
  • 52 Week Low
  • ₹2,327
  • 52 Week High
  • ₹3,021
  • Open Price₹2,840
  • Previous Close₹2,853
  • Volume58,380
  • 50 DMA₹2,720.35
  • 100 DMA₹2,665.87
  • 200 DMA₹2,640.76

Investment Returns

  • Over 1 Month + 0.83%
  • Over 3 Month + 13.38%
  • Over 6 Month + 9.84%
  • Over 1 Year + 6.32%

Smart Investing Starts Here Start SIP with Ajanta Pharma for Steady Growth!

Invest Now

Ajanta Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 35.2
  • PEG Ratio
  • 2.7
  • Market Cap Cr
  • 35,749
  • P/B Ratio
  • 8.3
  • Average True Range
  • 76.98
  • EPS
  • 81.21
  • Dividend Yield
  • 1
  • MACD Signal
  • 24.77
  • RSI
  • 61.78
  • MFI
  • 65.96

Ajanta Pharma Financials

Ajanta Pharma Technicals

EMA & SMA

Current Price
₹2,861.90
+ 9.2 (0.32%)
pointer
  • Bearish Moving Average 0
  • Bullish Moving Average 16
  • 20 Day
  • ₹2,781.47
  • 50 Day
  • ₹2,720.35
  • 100 Day
  • ₹2,665.87
  • 200 Day
  • ₹2,640.76

Resistance and Support

2855.17 Pivot Speed
  • R3 2,936.23
  • R2 2,906.97
  • R1 2,884.43
  • S1 2,832.63
  • S2 2,803.37
  • S3 2,780.83

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Ajanta Pharma is a specialty pharmaceutical company offering innovative, high-quality medicines across 30+ countries. With leadership in multiple therapeutic segments, Ajanta operates 7 state-of-the-art manufacturing facilities, supported by robust R&D capabilities and a strong global presence.

Ajanta Pharma has an operating revenue of Rs. 5,201.63 Cr. on a trailing 12-month basis. An annual revenue growth of 10% is good, Pre-tax margin of 26% is great, ROE of 24% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 5% and 9% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 5% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 75 which is a FAIR score but needs to improve its earnings, a RS Rating of 80 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B which is evident from recent demand for the stock, Group Rank of 59 indicates it belongs to a fair industry group of Medical-Generic Drugs and a Master Score of B is close to being the best. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Ajanta Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-01-30 Quarterly Results
2025-11-03 Quarterly Results & Interim Dividend
2025-07-28 Quarterly Results & Others To consider other business matters. per share(475%)Interim Dividend
2025-04-30 Audited Results & A.G.M.
2025-01-30 Quarterly Results
Date Purpose Remarks
2025-11-10 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-11-06 INTERIM Rs.28.00 per share(1400%)First Interim Dividend
2024-02-08 INTERIM Rs.26.00 per share(1300%)Second Interim Dividend
2023-08-04 SPECIAL Rs.15.00 per share(750%)Special Dividend
2023-08-04 INTERIM Rs.10.00 per share(500%)First Interim Dividend
View Ajanta Pharma Dividend History Arrow
Date Purpose Remarks
2022-06-23 Bonus Rs.0.00 issue in the ratio of 1:2 of Rs. 2/-.

Ajanta Pharma F&O

Ajanta Pharma Shareholding Pattern

66.25%
15.49%
2.65%
7.97%
0%
6.44%
1.2%

About Ajanta Pharma

  • NSE Symbol
  • AJANTPHARM
  • BSE Symbol
  • 532331
  • Managing Director
  • Mr. Yogesh M Agrawal
  • ISIN
  • INE031B01049

Similar Stocks to Ajanta Pharma

Ajanta Pharma FAQs

Ajanta Pharma share price is ₹2,861 As on 09 February, 2026 | 20:35

The Market Cap of Ajanta Pharma is ₹35748.6 Cr As on 09 February, 2026 | 20:35

The P/E ratio of Ajanta Pharma is 35.2 As on 09 February, 2026 | 20:35

The PB ratio of Ajanta Pharma is 8.3 As on 09 February, 2026 | 20:35

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23